Sarika Ramachandran, MD
Vice Chair of Diversity, Equity, and Inclusion. Associate Professor of Dermatology.Cards
About
Research
Clinical Care
Overview
Sarika Manoj Ramachandran, MD, is the medical director of Yale Medicine Dermatology in Branford, where she treats children, adolescents and adults for all their general dermatology needs. She also has a special interest in helping people with rheumatologic dermatology conditions such as cutaneous lupus, scleroderma and morphea, a condition that causes hardening and discoloration of the skin.
Because these and related conditions affect the skin (and often internal organs), she believes in taking a comprehensive approach to care. She is part of a dermatology-rheumatology program that treats people who have these disorders.
“It's a wonderful opportunity for the patient to be looked at from the skin as well as the systemic and rheumatologic perspectives,” she says. “Many treatments that we use for the skin can also benefit systemic disease. However, that’s not always the case—not all skin treatments are going to be the ones that we would use systemically for other organ systems. So, sometimes it's helpful to have that conversation in the room with the patient to figure out the best treatment options.”
Dr. Ramachandran believes this team approach helps prevent complications. “We can often get better results and prevent scarring and contractures (when skin, muscles or ligaments constrict, which can cause decreased mobility) when we treat quickly and aggressively,” she says.
An assistant professor of dermatology at Yale School of Medicine, Dr. Ramachandran is currently researching morphea and new treatments for autoimmune skin diseases such as lupus.
Clinical Specialties
Fact Sheets
Lichen Sclerosus
Learn More on Yale MedicineSquamous Cell Carcinoma
Learn More on Yale MedicineSkin Cancer
Learn More on Yale MedicineLichen Planus
Learn More on Yale Medicine
Yale Medicine News
News
News
- June 05, 2024
Improving Health Outcomes Through Community Outreach
- May 11, 2023
Discoveries & Impact (May 2023)
- October 05, 2022
Diversifying Lupus Clinical Trials One Patient at a Time
- May 11, 2022Source: CNBC
Doctors say these pandemic side effects are serious problems—and unlikely ‘to go away anytime soon’